Home/Filings/4/0001127602-23-024308
4//SEC Filing

Chopas James George 4

Accession 0001127602-23-024308

CIK 0001492422other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:20 PM ET

Size

4.5 KB

Accession

0001127602-23-024308

Insider Transaction Report

Form 4
Period: 2023-09-14
Chopas James George
VP/Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2023-09-14+2,50032,812 total
Footnotes (1)
  • [F1]This represents a Restricted Stock Unit award granted 09/14/23 that vest 25% every 6 months from grant date over a two year period subject to continued service.

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001836430

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:20 PM ET
Size
4.5 KB